Share
Journal Information
Issue
Vol. 23. Issue 5.Pages 243-308 (September - October 2017)
Editorials
Using evidence in clinical practice: A dream coming true in idiopathic pulmonary fibrosis
G. Sgalla, L. Richeldi
Rev Port Pneumol. 2017;23:245-6
Open access
Measuring sarcoidosis around the world: Using the same ruler
R.P. Baughman, E.E. Lower
Rev Port Pneumol. 2017;23:247-8
Open access
Erectile dysfunction and COPD – Cause or association
J.E. Scullion
Rev Port Pneumol. 2017;23:249-50
Open access
Original articles
Analysis of sarcoidosis in the Oporto region (Portugal)
A.V. Cardoso, P.C. Mota, N. Melo, S. Guimarães, C. Souto Moura, J.M. Jesus, R. Cunha, A. Morais
Rev Port Pneumol. 2017;23:251-8
Open access
Does any association exist between Chronic Obstructive Pulmonary Disease and Erectile Dysfunction? The DECODED study
M. Dias, M.J. Oliveira, P. Oliveira, I. Ladeira, R. Lima, M. Guimarães
Rev Port Pneumol. 2017;23:259-65
Open access
Assessment of dyspnea and dynamic hyperinflation in male patients with chronic obstructive pulmonary disease during a six minute walk test and an incremental treadmill cardiorespiratory exercise test
M. Alfonso, V. Bustamante, P. Cebollero, M. Antón, S. Herrero, J.B. Gáldiz
Rev Port Pneumol. 2017;23:266-72
Open access
Effects of exposure to biomass burning on pulmonary inflammatory markers and pulmonary function in individuals with COPD
D. Ramos, M. Proença, M.R. Leite, A.D. Ferreira, I.B. Trevisan, G.F.S. Brígida, G.Y. Tacao, E.M.C. Ramos
Rev Port Pneumol. 2017;23:273-9
Open access
The frequency of lung cancer in patients with pulmonary hamartomas: An evaluation of clinical, radiological, and pathological features and follow-up data of 96 patients with pulmonary hamartomas
G.H. Ekinci, O. Hacıömeroğlu, A. Ersev, L. Alpay, H. Özgen, A. Yılmaz
Rev Port Pneumol. 2017;23:280-6
Open access
Special article
Idiopathic pulmonary fibrosis in the era of antifibrotic therapy: Searching for new opportunities grounded in evidence
C. Robalo-Cordeiro, P. Campos, L. Carvalho, A. Borba, S. Clemente, S. Freitas, S. Furtado, J.M. Jesus, ... A. Morais
Rev Port Pneumol. 2017;23:287-93
Open access
Research letters
Lung transplant outpatient clinic at Centro Hospitalar São João – 10 year review
D. Araújo, C. Damas
Rev Port Pneumol. 2017;23:294-5
Open access
Diagnostic yield of transbronchial lung cryobiopsy in interstitial lung diseases
R. Marçôa, R. Linhas, D. Apolinário, S. Campainha, A. Oliveira, C. Nogueira, A. Loureiro, J. Almeida, ... S. Neves
Rev Port Pneumol. 2017;23:296-8
Open access
Impact of bariatric surgery in obstructive sleep apnea in obese patients
I.M. Guerreiro, M. Branco, S. Moreira, J. Valença
Rev Port Pneumol. 2017;23:298-9
Open access
Pulmonary tuberculosis: Resistance pattern to first line anti-tuberculosis drugs in the Coimbra District, 2000–2011
R. Eufrásio, M. Alcobia, L. Correia
Rev Port Pneumol. 2017;23:300-2
Open access
Letters to the editor
Does omalizumab impair glucose homeostasis in a patient with severe persistent asthma and type 2 diabetes mellitus?
S. Hamada, A. Kuroe, M. Tsukino
Rev Port Pneumol. 2017;23:303-4
Open access
Allergic bronchopulmonary aspergillosis treated successfully with omalizumab
R. Aguiar, N.P. Fernandes, A. Lopes, C. Lopes
Rev Port Pneumol. 2017;23:304-6
Open access
Atypical pyoderma gangrenosum simulating pectoral abscess managed using negative pressure wound therapy
J. Soro-García, E.M. García-Fontán, R. Carrasco-Rodríguez, M. Blanco-Ramos, M.A. Cañizares-Carretero
Rev Port Pneumol. 2017;23:306-7
Open access
Special content about COVID-19
- Assisted mobilisation in critical patients with COVID-19
- Two years of COVID-19: Trends in rehabilitation
- Comparison of different field tests to assess the physical capacity of post-COVID-19 patients
- New insights in circulating peptidome to differentiate mild to severe COVID-19 patients: Preliminary report
Open access
This work is licensed under a Creative Commons Attribution 4.0 International License.
Publish in
Pulmonology
